Theriva Biologics Inc. (TOVX) Stock Analysis

Theriva Biologics Inc. (TOVX) is a publicly traded company in the HEALTHCARE sector. It trades at $0.29, carries a market capitalization of $12.94M. This page summarizes the public market data, fundamentals, and frequently asked questions for TOVX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $0.29
• Market Cap: $12.94M
• EPS: $-0.58
• 52-Week High: $0.86
• 52-Week Low: $0.16

Market Sentiment

Theriva Biologics Inc. currently has a Bullish sentiment score of 0.40.

About Theriva Biologics Inc.

Theriva Biologics Inc. (TOVX) is a clinical-stage biotechnology company headquartered in Rockville, Maryland, dedicated to addressing significant unmet medical needs through the development of innovative biologic therapies. Utilizing its proprietary technology platforms, the company focuses on creating targeted treatment solutions that aim to enhance patient outcomes across various therapeutic areas. With a promising pipeline and a highly skilled team, Theriva is well-positioned to advance it...

GNG Research Analysis

GNG Research scores Theriva Biologics Inc. (TOVX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TOVX.

Frequently Asked Questions

Does TOVX pay dividends?

Theriva Biologics Inc. (TOVX) does not currently pay a regular dividend.

What is TOVX's market cap?

Theriva Biologics Inc. (TOVX) has a market capitalization of $12.94M with a current stock price of $0.29.